Bioassays for the detection of hormonal activities

Endocrine-Disrupting Chemicals in Food

Volumn , Issue , 2009, Pages 259-290

  Bovee, T F H ^a   Hoogenboom, L A P ^a   Thomson, B M ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b ESR Christchurch Science Centre   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954000550     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845695743.3.259     Document Type: Chapter

References (140)

1. Aarts J.M.M.J.G., Denison M.S., Cox M.A., Schalk M.A.C., Garrison P.M., Tullis K., De Haan L.H.J., Brouwer A. Species-specific antagonism of Ah receptor action by 2,2',5,5'-tetrachloro- and 2,2',3,3',4,4'-hexachlorobiphenyl. Eur J Pharmacol Environ Toxicol 1995, 293(4):463-474.
2. Allen A., Doisy E.A. An ovarian hormone. Preliminary report on its location, extraction and partial purification and action in test animals. J Am Med Assoc 1923, 81:819-821.
3. Arnold S.F., Collins B.M., Robinson M.K., Guillette L.J., Mclachlan J.A. Differential interaction of natural and synthetic estrogens with extracellular binding proteins in a yeast estrogen screen. Steroids 1996, 61:642-646.
4. Behnisch P.A., Hosoe K., Brouwer A., Sakai S. Screening of dioxin-like toxicity equivalents for various matrices with wildtype and recombinant rat hepatoma H4IIE cells. Toxicol Sci 2002, 69(1):125-130.
5. Behnisch P.A., Hosoe K., Sakai S. Brominated dioxin-like compounds: in vitro assessment in comparison to classical dioxin-like compounds and other polyaromatic compounds. Environ Int 2003, 29(6):861-877.
6. Berg M., HundÍS K., Thiericke R., Moore T., Posten C. Miniaturization of a functional transcription assay in yeast (human progesterone receptor) in the 384- and 1536-well plate format. J Biomol Screening 2000, 5:71-76.
7. Bergeron J.M., Crews D., Mclachlan J.A. PCBs as environmental oestrogens. Turtle sex determination as a biomarker of environmental contamination. Environ Health Perspect 1994, 102:780-781.
8. Bitman J., Cecil H.C. Estrogenic activity of DDT analogs and polychlorinated biphenyls. J Agric Food Chemi 1970, 18:1108-1112.
9. Blankvoort B.M.J., De Groene E.M., Van Meeteren-Kreikamp A.P., Witkamp R.F., Rodenburg R.J.T., Aarts J.M.M.J.G. Development of an androgen reporter gene assay (AR-LUX) utilising a human cell line with an endogenously regulated androgen receptor. Anal Biochem 2001, 298(1):93-102.
10. Bovee T.F.H., Hoogenboom L.A.P., Traag W.A., Zuidema T., Horstman J.H.J., Aarts J.M.M.J.G., Murk T.J., Brouwer A., Denison M.S., Kuiper H.A. Biological screening of Ah receptor agonist activity in butter fat and coconut oil by means of chemical-activated luciferase expression in a genetically engineered cell line (CALUX). Organohalogen Compounds 1996, 27:303-308.
11. Bovee TFH., Hoogenboom L.A.P., Hamers A.R.M., Traag W.A., Zuidema T., Aarts J.M.M.J.G., Brouwer A., Kuiper H.A. Validation and use of the CALUX-bioassay for the determination of dioxins and PCBs in bovine milk. Food Add Contam 1998, 15(8):863-875.
12. Bovee T.F.H., Helsdingen J.R., Koks P.D., Kuiper H.A., Hoogenboom L.A.P., Keijer J. Development of a rapid yeast estrogen bioassay, based on the expressing of green fluorescent protein. Gene 2004, 325:187-200.
13. Bovee T.F.H., Helsdingen J.R., Rietjens I.M.C.M., Keijer J., Hoogenboom L.A.P. Rapid yeast estrogen bioassays stably expressing human estrogen receptors and, and green fluorescent protein: a comparison of different compounds with both receptor types. J Steroid Biochem Mol Biol 2004, 91(3):99-109.
14. Bovee T.F.H., Heskamp H.H., Hamers A.R.M., Hoogenboom L.A.P., Nielen M.W.F. Validation of a rapid yeast estrogen bioassay, based on the expression of green fluorescent protein, for the screening of estrogenic activity in calf urine. Anal Chim Acta 2005, 529(1-2):57-64.
15. Bovee T.F.H., Bor G., Heskamp H.H., Hoogenboom L.A.P., Nielen M.W.F. Validation and application of a robust yeast estrogen bioassay for the screening of estrogenic activity in animal feed. Food Add Contam 2006, 23(6):556-568.
16. Bovee T.F.H., Helsdingen J.R., Hamers A.R.M., Van Duursen M.B.M., Nielen M.W.F., Hoogenboom L.A.P. A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists. Anal Bioanul Chem 2007, 389:1549-1588.
17. Bovee T.F.H., Hamers A.R.M., Schoonen W.G.E.J., Jorge Bento M., Penijnburg A.A.C.M. Screening of synthetic and plant-derived compounds for (anti-) estrogenic and (anti-) androgenic activities. Anal Bioanul Chem 2006, 390:1111-1119.
18. Bovee T.F.H., Lommerse J.P.M., Peijnenburg A.A.C.M., Antunes Fernandes E., Nielen M.W.F. A new highly androgen specific yeast biosensor, enabling optimisation of (Q)SAR model approaches. J Steroid Biochem Mol Biol 2008, 108:121-131.
19. Breithofer A., Graumann K., Scicchitano M.S., Karathanasis S.K., Butt T.R., Jungbauer A. Regulation of human estrogen receptor by phytoestrogens in yeast and human cells. J Steroid Biochem Mol Biol 1998, 67:421-429.
20. Brodie J., Mcewan I.J. Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding. J Mol Endocrinol 2005, 34:603-615.
21. Canton R.F., Bovee T.F.H., Daamen F., Van Duursen M., Van Den Berg M. In vitro antiandrogenicity of PBDEs, HBCD, TBP and hydroxylated and methoxylated PBDEs based on a yeast assay 2007, Short abstract.
22. Celander M., Weisbrod R., Stegeman J.J. Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture. Biochem Biophys Res Comm 1997, 232(3):749-753.
23. Charles G.D., Bartels M.J., Zacharewski T.R., Gollapudi B.B., Freshour N.L., Carney E.W. Activity of benzoa]pyrene and its hydroxylated metabolites in an estrogen receptor reporter gene assay. Tox Sci 2000, 55:320-326.
24. Chatterjee S., Kumar V., Majumder C.B., Roy P. Screening of some anti-progestin endocrine disruptors using a recombinant yeast-based in vitro bioassay. Toxicology in Vitro 2008, 22:788-798.
25. Coecke S., et al. Metabolism: A bottleneck in in vitro toxicological test development. ATLA 2006, 34:49-84. The report and recommendations of ECVAM Workshop 54.
26. Courant F., Antignac J.-P., Maume D., Monteau F., Andersson A.-M., SkakkebæK N., Andre F., Le Bizec B. Exposure assessment of prbubertal children to steroid endocrine disrupters; 1. Analytical strategy for estrogens measurement in plasma at ultra-trace level. Anal Chim Acta 2007, 586(1-2):105-114.
27. Dauvois S., Danielian P.S., White R., Parker M.G. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci 1992, 89:4037-4041.
28. Denison M.S., Zhao B., Baston D.S., Clark G.C., Murata H., Han D. Recombinant cell bioassay systems for the detection and relative quantitation of halogenated dioxins and related chemicals. Talanta 2004, 63:1123-1133.
29. Ec Commission Directive 2002/69/EC of 26 July 2002 laying down the sampling methods and the methods of analysis for the official control of dioxins and the determination of dioxin-like PCBs in foodstuffs. Official J Eur Comm 2002, L209:5-14.
30. Ec Commission Directive 2002/70/EC of 26 July 2002 establishing requirements for the determination of levels of dioxins and dioxin-like PCBs in feedingstuffs. Official J Eur Comm 2002, L209:15-21.
31. Egner R., Rosenthal F.E., Kralli A., Sanglard D., Kuchler K. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol Biol Cell 1998, 9:523-543.
32. Elkak A.E., Mokbel K. Pure antiestrogens and breast cancer. Curr Med Res Opin 2001, 17:282-289.
33. Fang H., Tong W., Perkins R., Soto A.M., Prechtl N.V., Sheehan D.M. Quantitative comparison of in vitro assays for estrogenic activities. Environ Health Perspect 2000, 108:723-729.
34. Fertuck K.C., Matthews J.B., Zacharewski T.R. Hydroxylated benzoa]pyrene metabolites are responsible for in vitro estrogen receptor-mediated gene expression induced by benzoa]pyrene, but do not elicit uterotrophic effects in vivo. Tox Sci 2001, 59:231-240.
35. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babaï D., Portier C.J., Mcdonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharm 1997, 143:205-212.
36. Galey F.D., Terra R., Walker R., Adaska J., Etchebarne M.A., Puschner B., Fisher E., Whitlock R.H., Rocke T., Willoughby D., Tor E. Type C botulism in dairy cattle from feed contaminated with a dead cat. J Vet Diagn Investig 2000, 12:204-209.
37. Garcia-Reyero N., Grau E., Castillo M., Lopez De Alda M.J., Barcelo D., Pina B. Monitoring of endocrine disruptors in surface waters by the yeast recombinant assay. Environ Toxicol Chem 2001, 20:1152-1158.
38. Gibson M.K., Nemmers L.A., Beckman W.C., Davis V.L., Curtis S.W., Korach K.S. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 1991, 129:2000-2010.
39. Graumann K., Breithofer A., Jungbauer A. Monitoring of estrogen mimics by a recombinant yeast assay: synergy between natural and synthetic compounds?. Sci Total Env 1999, 225:69-79.
40. Gustafsson J.A. Estrogen receptor - a new dimension in estrogen mechanism of action. J Endocrinol 1999, 163:379-383.
41. Haelens A., Verrijdt G., Callewaert L., Christiaens V., Schauwaers K., Peeters B., Rombauts W., Claessens F. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Biochem J 2003, 369:141-151.
42. Han D., Nagy S.R., Denison M.S. Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. Biofactors 2004, 20:11-22.
43. Hecker H., Giesy J.P. Novel trends in endocrine disruptor testing: the H295R steroidogenesis assay to identify inducers and inhibitors of hormone production. Anal Bioanal Chem 2008, 390:287-291.
44. Heneweer M., Van Den Berg M., Sanderson J.T. A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase. Toxicol Lett 2004, 146:183-194.
45. Henley D.V., Lipson N., Korach K.S., Bloch C.A. Prepuberal gynecomastia linked to lavender and tea tree oils. New Eng J Med 2007, 356:479-485.
46. Herschberger L.G., Shiply E.G., Meyer R.K. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator and muscle method. Proc Soc Exp Biol Med 1953, 83:175-180.
47. Hoogenboom L.A.P., Hamers A.R.M., Bovee T.F.H. Bioassays for the detection of growth-promoting agents, veterinary drugs and environmental contaminants in food. The Analyst 1999, 124:79-85.
48. Hoogenboom L.A.P., De Haan L., Hooijerink D., Bor G., Murk A.J., Brouwer A. Estrogenic activity of estradiol and its metabolites in the ER-CALUX assay with human T47D breast cells. Acta Pathol Microbiol Immunol Scand 2001, 109:101-107.
49. Hoogenboom L.A.P., Bovee T.F.H., Portier L., Bor G., Weg G Van Der, Onstenk C., Traag W.A. The German bakery waste incident; use of a combined approach of screening and confirmation for dioxins in feed and food. Talanta 2004, 63(5):1249-1253.
50. Hoogenboom L.A.P., Van Eijkeren J.C.H., Zeilmaker M.J., Mengelers M.J.B., Herbes R., Immerzeel J., Traag W.A. A novel source for dioxins present in recycled fat from gelatin production. Chemosphere 2007, 68:814-823.
51. Hungerford J.M. Official Methods of Analysis. AOAC Official Method 959.08. Paralytic shellfish poison 1995, AOAC International, Arlington, VA, Chapter 35.1.37. 16th.
52. Jenkins R.L., Wilson E.M., Angus R.A., Howell W.M., Kirk M. Androstenedione and progesterone in the sediment of a river receiving paper mill effluent. Toxicol Sci 2003, 73:53-59.
53. Jobling S., Reynolds T., White R., Parker M.G., Sumpter J.P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 1995, 103:582-587.
54. Jordan V.C. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. J Medicinal Chem 2003, 46:883-908.
55. Juretic A., Saric N., Bisof V., Basic-Coretic M. Fulvestrant: a new agent in endocrine treatment for breast cancer. Lijec Vjesn 2006, 128:31-36.
56. Kennedy S.W., Lorenzen A., James C.A., Collins B.T. Ethoxyresorufin O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Anal Biochem 1993, 211:102-112.
57. Klein K.O., Baron J., Colli M.J., Mcdonnell D.P., Cutler G.B. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 1994, 94:2475-2480.
58. Körner W., Vinggaard A.M., Térouanne B., Ma R., Wieloch C., Schlumpf M., Sultan C., Soto A.M. Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. Environ Health Perspect 2004, 112(6):695-702.
59. Lai K.P., Wong M.H., Wong C.K.C. Modulation of AhR-mediated CYP1A1 mRNA and EROD activities by 17 beta-estradiol and dexamethasone in TCDD-induced H411E cells. Toxicol Sci 2004, 78(1):41-49.
60. Leblanc K., Sexton E., Parent S., Belanger G., Dery M.C., Boucher V., Asselin E. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. Int J Oncol 2007, 30:477-487.
61. Ledoux M., Hall S. Proficiency testing of eight French laboratories in using the AOAC mouse bioassay for paralytic shellfish poisoning: interlaboratory collaborative study. J AOAC Int 2000, 83:305-310.
62. Lee H.J., Lee Y.S., Kwon H.B., Lee K. Novel yeast bioassay system for detection of androgenic and antiandrogenic compounds. In Vitro Toxicol 2003, 17:237-244.
63. Legler J., Van Den Brink C.E., Brouwer A., Murk A.J., Van Der Saag P.T., Vethaak D.A., Van Der Burg B. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 1999, 48:55-66.
64. Legler J., Dennekamp M., Vethaak A.D., Brouwer A., Koeman J.H., Van Der Burg B., Murk A.J. Detection of estrogenic activity in sediment-associated compounds using in vitro reporter gene assays. Sci Total Environ 2002, 293:69-83.
65. Le Guevel R., Pakdel F. Streamlined beta-galactosidase assay for analysis of recombinant yeast response to estrogens. Biotechniques 2001, 30:1000-1004.
66. Lemaire G., Terouanne B., Mauvais P., Michel S., Rahmani R. Effect of organochlorine pesticides on human androgen receptor activation in vitro. Toxicol Appl Pharmacol 2004, 196:235-246.
67. Leskinen P., Michelini E., Picard D., Karp M., Virta M. Bioluminescent yeast assays for detecting estrogenic and androgenic activity in different matrices. Chemosphere 2005, 61:259-266.
68. Li J., Cui Q., Ma M., Rao K.F., Wang Z.J. Recombinant hPR gene yeast for assessing in drinking water. Huan Jing Ke Xue 2006, 27:2463-2466.
69. Machala M., Vondracek J., Blaha L., Ciganek M., Neca J. Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutation Res 2001, 497(1-2):49-62.
70. Maillard S., Gauduchon J., Marsaud V., Gouilleux F., Connault E., Opolon P., Fattal E., Sola B., Renoir J.M. Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma. J Steroid Biochem Mol Biol 2006, 100:67-78.
71. Mak P., Mcdonnell D.P., Weigel N.L., Schrader W.T., O'Malley B.W. Expression of functional chicken oviduct progesterone receptors in yeast. J Biol Chem 1989, 264:21613-21618.
72. Mcinerney E.M., Weis K.E., Sun J., Mosselman S., Katzenellenbogen B.S. Transcription activation by the human estrogen receptor subtype (ER) studied with ER and ER receptor chimeras. Endocrinology 1998, 139:4513-4522.
73. Meenagh S.A., Elliot C.T., Buick R.K., Izeboud C.A., Witkamp R.F. The preparation, solubilisation and binding characteristics of a 2-adrenoceptor isolated from transfected Chinese hamster cells. The Analyst 2001, 126:491-494.
74. Meenagh S.A., Mcevoy J.D.G., Elliott C.T. Determination of carazolol residues in porcine tissue by radioreceptor assay. Anal Chim Acta 2002, 462:149-156.
75. Michelini E., Leskinen P., Virta M., Karp M., Roda A. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. Biosens Bioelectronics 2005, 20:2261-2267.
76. Milligan S.R., Balasubramanian A.V., Kalita J.C. Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environ Health Perspect 1998, 106:23-26.
77. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M., Nohara T., Ogawa S., Inoue S., Muramatsu M., Masamune Y. Interaction of phytoestrogens with estrogen receptors and. Biol Pharm Bull 2001, 24:351-356.
78. Mueller S.O. Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J Chromatogr B 2002, 777:155-165.
79. Murk A.J., Legler L., Denison M.S., Giesy J.P., Van De Guchte C., Brouwer A. Chemical-activated luciferase gene expression (CALUX): a novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Fundam Appl Toxicol 1996, 33:149-160.
80. Naderi-Kalali B., Allameh A., Rasaee M.J., Bach H.J., Behechti A., Doods K., Kettrup A., Schramm K.W. Suppressive effects of caraway (Carum carvi) extracts on 2,3,7,8-tetrachloro-dibenzo-p-dioxin-dependent gene expression of cytochrome P450 1A1 in the rat H4IIE cells. Toxicol In Vitro 2005, 19(3):373-377.
81. Nielen M.W.F., Elliott C.T., Boyd S.A., Courtheyn D., Essers M.L., Hooijerink H.H., Van Bennekom E.O., Fuchs R.E.M. Identification of an unknown beta-agonist in feed by liquid chromatography/bioassay/quadrupole time-of-flight tandem mass spectrometry with accurate mass measurement. Rapid Comm Mass Spect 2003, 17(14):1633-1641.
82. Nielen M.W.F., Bovee T.F.H., Van Engelen M.C., Rutgers P., Hamers A.R.M., Van Rhijn J.A., Hoogenboom L.A.P. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification. Anal Chem 2006, 78:424-431.
83. NIH ICCVAM Evaluation of In Vitro Methods for Detecting Potential Endocrine Disruptors. 2003, Publication No: 03-4503.
84. Nouws J.F.M., Broex N.J.G., Den Hartog J.M.P., Driesens F. The new Dutch kidney test. Arch Lebensmittelhyg 1988, 39:135-138.
85. Nouws J.F.M., Loeffen G., Schouten J., Van Egmond H., Keukens H., Stegeman H. Testing of raw milk for tetracycline residues. J Dairy Sci 1998, 81:2341-2345.
86. Orwoll E.S., Stribrska L., Ramsey E.E., Keenan E.J. Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 1991, 49:183-187.
87. Owens W., Gray L.E., Zeiger E., Walker M., Yamasaki K., Ashby J., Jacob E. The OECD program to validate the rat Herschberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies. Environ Health Perspect 2007, 115:671-678.
88. Paris F., Balaguer P., Térouanne B., Servant N., Lacoste C., Cravedi J.-P., Nicolas J.-C., Sultan C. Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol Cell Endocrinol 2002, 193:43-49.
89. Peperzak L. Future increase in harmful algal blooms in the Noth Sea due to climate change. Water Sci Technol 2005, 51:31-36.
90. Pereira J.J., Ziskowski J., Marcaldo-Allen R., Kuropat C., Luedke D., Gould E. Vitellogenin in winter flounder (Pleuronectes americanus) from Long Island Sound and Boston harbour. Estuaries 1992, 15:289-297.
91. Petit F., Valotaire Y., Pakdel F. Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae. Eur J Biochem 1995, 233:584-592.
92. Petz L.N., Ziegler Y.S., Schultz J.R., Nardulli A.M. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. Mol Endocrinol 2004, 18:521-532.
93. Pham T.A., Hwung Y.P., Santiso M.D., Mcdonnell D.P., O'Malley B.W. Ligand-dependent and independent function of the transcriptivation regions of the human estrogen receptor in yeast. Mol Endocrinol 1992, 6:1043-1050.
94. Pike M.C., Spicer D.V., Dahmoush L., Press M.F. Estrogens, progesterons, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993, 15:17-35.
95. Poland A., Knutson J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Ann Rev Pharmacol Toxicol 1982, 22:517-542.
96. Pons M., Gagne D., Nicolas J.C., Mehtali M. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques 1990, 9:450-459.
97. Ramamoorthy K., Wang F., Chen I., Norris J.D., Mcdonnell D.P., Leonard L.S., Gaido K.W., Bocchinfuso W.P., Korach K.S., Safe S. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology 1997, 138:1520-1527.
98. Rehmann K., Schramm K., Kettrup A.A. Applicability of a yeast oestrogen screen for the detection of oestrogen-like activities in environmental samples. Chemosphere 1999, 38:3303-3312.
99. Rijk J.C.W., Bovee T.F.H., Groot M.J., Peijnenburg A.A.C.M., Nielen M.W.F. Metabolic activation and TOFMS identification of prohormones using liver S9 in combination with a highly androgen-specific yeast bioassay 2006, Short abstract.
100. Rogers J.M., Denison M.S. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals. In Vitro Molec Toxic 2000, 13(1):67-82.
101. Routledge E.J., Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products using a recombinant yeast screen. Environ Toxicol Chem 1996, 15:241-248.
102. Sanderson J.T., Seinen W., Giesy J.P., Van Den Berg M. 2-Chloro-striazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?. Toxicol Sci 2000, 54:121-127.
103. Sawyer T.W., Vatcher A.D., Safe S. Comparative aryl hydrocarbon hydroxylase induction of commercial PCBs in Wistar rats and hepatoma H4IIE cells in culture. Chemosphere 1984, 13:695-701.
104. Schoonen W.G., Vermeulen G.J., Deckers G.H., Verbost P.M., Kloosterboer H.J. Antiprogestins: their mechanisms of action and the consequences for compound selection by in vitro and in vivo studies. Curr Topics Steroid Res 1999, 2:15-54.
105. Schoonen W.G., Deckers G., De Gooyer M.E., De Ries R., Kloosterboer H.J. Hormonal properties of norethisterone, 7-methyl-noresthisterone and their derivates. J Steroid Biochem Mol Biol 2000, 74:213-222.
106. Schrenk D., Lipp H.-P., Wiesmüller T., Hagenmaier H., Bock K.W. Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparison between defined mixtures and their constituents. Arch Toxicol 1991, 65:114-118.
107. Shaffer P.L., Jivan A., Dollins D.E., Cleassens F., Gewirth D.T. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci 2004, 101:4758-4763.
108. Sharpe R.M., Fisher J.S., Millar M.M., Jobling S., Sumpter J.P. Gestational and lactational exposure to xenoestrogens results in reduced testicular size and sperm production. Environ Health Perspect 1995, 103(12):1136-1143.
109. Shelby M.D., Newbold R.R., Tully D.B., Chae K., Davis V.L. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 1996, 104(12):1296-1300.
110. SkakkebæK N.E., Jørgensen N., Main K.M., Rajpert-Demeyts E., Leffers H., Andersson A., Juul A., Carlsen E., Mortensen G.K., Jensen T.K., Toppari J. Is human fecundity declining?. Int J Andrology 2006, 29:2-11.
111. Sonneveld E., Jansen H.J., Riteco J.A.C., Brouwer A., Van Der Burg B. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci 2005, 83:136-148.
112. Sonneveld E., Riteco J.A.C., Jansen H.J., Pieterse B., Brouwer A., Schoonen W.G., Van Der Burg B. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol Sci 2006, 89:173-187.
113. Sonneveld E., Jansen H.J., Man S., Jonas A., Brouwer A., Burg B.Van Der Glucocorticoid mediated expression of dioxin target genes in rat H4IIE cells but not in human HEPG2 and T47D cells. Organohal Comp 2006, 68:564-567.
114. Sonneveld E., Jonas A., Meijer O.C., Brouwer A., Van Der Burg B. Glucocorticoid-enhanced expression of dioxin target genes through regulation of the rat aryl hydrocarbon receptor. Toxicol Sci 2007, 99:455-469.
115. Soto A.M., Justicia H., Wray J.W., Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polysterene. Environ Health Perspect 1991, 92:167-173.
116. Soto A.M., Lin T.-M., Justicia H., Silvia R.M., Sonnenschein C.M. Chemically Induced Alterations in Sexual Development: The Wildlife/Human Connection. An "in culture" bioassay to assess the estrogenicity of xenobiotics 1992, 295-309. Princeton Scientific Publishing, Princeton, NJ. T. Colborn, C. Clement (Eds.).
117. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Olea-Serrano F. The E-screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 1995, 103(7):113-122.
118. Soto A.M., Lin T.M., Justicia H., Silvia R.M., Sonnenschein C. An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-SCREEN). J Clean Techn, Environm Toxicol Occup Med 1998, 7(3):331-343.
119. Soto A.M., Calabro J.M., Prechtl N.V., Yau A.Y., Orlando E.F., Daxenberger A., Kolok A.S., Guilette L.J., Le Bizec B., Lange I.G., Sonnenschein C. Androgenic and estrogenic activity in water bodies receiving cattle feedlot effluent in Eastern Nebraska, USA. Environ Health Perspect 2004, 112(3):346-352.
120. Soto A.M., Maffini M.V., Schaeberle C.M., Sonnenschein C. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Practice Res Clin Endocrin Metab 2006, 20:15-33.
121. Sumpter J.P. Current Trends in Comparative Endocrinology. The purification, radioimmunoassay and plasma levels of vitellogenin from the rainbow trout, Salmo gairdneri 1985, 355-357. University Press, Hong Kong. B. Lofts, W.N. Holmes (Eds.).
122. Szelei J., Jimenez J., Soto A.M., Luizzi M.F., Sonnenschein C. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 1997, 138(4):1406-1412.
123. Tester P.A. Harmful marine phytoplankton and shellfish toxicity. Potential consequences of climate change. Ann N Y Acad Sci 1994, 740:69-76.
124. Thomson B., Cressey P.J., Shaw I.C. Dietary exposure to xenoestrogens in New Zealand. J Environ Monit 2003, 5:229-235.
125. Tillitt D.E., Giesy J.P., Ankley G.T. Characterization of the H4IIE rat hepatoma cell bioassay as a tool for assessing toxic potency of planar halogenated hydrocarbons in environmental samples. Environ Sci Technol 1991, 25:87-92.
126. Tutulan-Cunita A.C., Mikoshi M., Mizunuma M., Hirata D., Miyakawa T. Mutational analysis of the yeast multidrug resistance ABC transporter Pdr5p with altered drug specificity. Genes to Cells 2005, 10:409-420.
127. Tyler C.R., Sumpter J.P. The development of a radioimmunoassay for carp, Cyprinus carpio, vitellogenin. Fish Physiol Biochemi 1990, 8:129-140.
128. Ulrich E.M., Caparell-Grant A., Jung S.-H., Hites R.A., Bigsby R.M. Environmentally relevant xenoestrogen tissue concentrations correlated to biological responses in mice. Environ Health Perspect 2000, 108(10):973-977.
129. Van Der Kerkhof E.G., De Graaf I.A., De Jager M.H., Groothuis G.M. Induction of phase I and II drug metabolism in rat small intestine and colon in vitro. Drug Metab Dispos 2007, 35:898-907.
130. Van Leengoed L., Kluivers M., Herbes R., Langendijk P., Stephany R., Van Den Berg M., Seinen W., Grinwis G., Van Der Lugt J., Meulders F., Geudeke T., Verheijden J. The weakest link: Medroxyprogesterone acetate in pig feed. Tijdschrift Diergeneeskunde 2002, 127:516-519.
131. Van Liempd S.M., Kool J., Niessen W.M.A., Van Elswijk D.E., Irth H., Vermeulen N.P.E. On-line formation, separation, and estrogen receptor receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators. Drug Metabol Dispos 2006, 34:1640-1649.
132. Waller C.L., Juma B.W., Gray L.E., Kelce W.R. Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol 1996, 137:219-227.
133. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors and. Biochem Biophys Res Commun 1997, 236:140-145.
134. Wiebel F.J., Cikryt P. Dexamethasone-mediated potentiation of P450IA1 induction in H4IIEC3/T hepatoma cells is dependent on a time-consuming process and associated with induction of the Ah receptor. Chem-Biol Interact 1990, 76:307-320.
135. Willemsen P., Scippo M., Maghuin-Rogister G., Martial J.A., Muller M. Use of specific bioluminescent cell lines for the detection of steroid hormone (ant)agonists in meat producing animals. Anal Chim Acta 2002, 473:119-126.
136. Willemsen P., Scippo M., Kausel G., Figueroa J., Maghuin-Rogister G., Martial J.A., Muller M. Use of reporter cell lines for detection of endocrine-disrupter activity. Anal Bioanal Chem 2004, 378:655-663.
137. Willemsen P., Scippo M., Maghuin-Rogister G., Martial J.A., Muller M. Enhancement of steroid receptor-mediated transcription for the development of highly responsive bioassays. Anal Bioanal Chem 2005, 382:894-905.
138. Witters H.E., Vangenechten C., Berckmans P. Detection of estrogenic activity in Flemish surface waters using an in vitro recombinant assay with yeast cells. Water Sci Technol 2001, 43:117-123.
139. Yoon K., Pallaroni L., Stoner M., Gaido K., Safe S. Differential activation of wild-type and variant forms of estrogen receptor by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements. J Steroid Biochem Mol Biol 2001, 78:25-32.
140. Zacharewski T. In vitro bioassays for assessing estrogenic substances. Environment Sci Technol 1997, 31:613-623.